Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81970180 to MZ)
Tianjin Municipal Transportation Commission Science and Technology Development Plan Project (TJWJ2022QN030 to MZ)
the Key projects of Tianjin Applied Basic Research and Multi-Investment Fund (21JCZDJC01240)
the Science and Technology Project of Tianjin Municipal Health Committee (TJWJ2022XK018 to MZ)
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 23 December 2024
First Online: 22 January 2025
Declarations
:
: Informed consent was provided with lymphoma and healthy donors agreed to participate in this experiment within a clinical trial. Ethics approval was provided at the Department of Hematology at Tianjin First Central Hospital (Tianjin, China) (ChiCTR-ONN-16009862; Tianjin First Central Hospital Medical Ethics Committee).
: The authors declared no potential conflicts of interest concerning the research, authorship, and/or publication of this article.
